Agilent Technologies Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Agilent Technologies Inc 's ROA in the third quarter of 2026?
Agilent Technologies inc achieved a return on average assets (ROA) of 10.97 % in its third quarter of 2026, this is above A's average return on assets of 9.73%.
Agilent Technologies Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $13 billion

ROA fell compared to the second quarter of 2026, despite the net income growth of 6.78% from the second quarter of 2026.

However, within the Healthcare sector 91 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jul 31 2026 quarter, so far to 548, from total ROA ranking in the second quarter of 2026 at 672.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jul 31 2026) III. Quarter	(Apr 30 2026) II. Quarter	(Jan 31 2026) I. Quarter	(Oct 31 2025) IV. Quarter	(Jul 31 2025) III. Quarter
Y / Y Total Assets Change	13.18 %	8.58 %	7.44 %	7.44 %	11.19 %
Y / Y Net Income Change	7.74 %	57.67 %	-4.09 %	23.65 %	19.15 %
Net Income (TTM) in million	1,440	1,414	1,290	1,303	1,220
Return On Assets (TTM)	10.97 %	11.12 %	10.35 %	10.65 %	10.15 %
A's Total Ranking	# 548	# 672	# 569	# 604	# 616
Total Assets (TTM) in million	13,837	13,201	12,727	12,727	12,226
Seq. Total Assets Change	4.82 %	3.72 %	0 %	4.1 %	0.56 %
Seq. Net Income Change	6.78 %	11.15 %	-29.72 %	29.17 %	56.28 %

A's 5 Years Annual ROA >> Back to A Management Effectiveness >> Compare A ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 4
Sector	# 92
Overall	# 555

Return On Assets Statistics
High	Average	Low
42.51 %	9.73 %	-0.44 %
(Oct. 31, 2006)		(Oct. 31, 2009)

Financial Statements
Agilent Technologies Inc 's Assets	$ 13,837 million	A's Balance sheet
Agilent Technologies Inc 's Income	$ 362 million	Quarterly A's Income Statement
A's Income by Division		See A's Income by Division

Annual Return On Assets	(Oct 31 2025) FY 2025	(Oct 31 2024) FY 2024	(Oct 31 2023) FY 2023	(Oct 31 2022) FY 2022	(Oct 31 2021) FY 2021
Y / Y Total Assets Change	7.44 %	10.06 %	2.19 %	-1.62 %	11.2 %
Total Assets in million	12,727	11,846	10,763	10,532	10,705
Y / Y Net Income Change	1.09 %	3.95 %	-1.12 %	3.64 %	68.29 %
Net Income in million	1,303	1,289	1,240	1,254	1,210
Annual Return On Assets	10.24 %	10.88 %	11.52 %	11.91 %	11.3 %

A's 5 Years Annual ROA >> Back to A Management Effectiveness >> Compare A ROA to its Competitors

Comment on A's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 10.24 %, despite annual net income growth of 1.09 % to $1,303.00 million, from $1,289.00 million a year ago, as A's assets increase to $12,727.00 million, by 1.09 %.

More Return On Assets Ratios
A's' Return on Assets at Yahoo Finance
Laboratory Analytical Instruments Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
A's Roa Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for A's Competitors
Subscribers only: Roa for Agilent Technologies Inc 's Suppliers
Subscribers only: Return On Assets for A's Customers

You may also want to know
A's Roi	A's Inventory Turnover Ratio	A's Growth Rates	A's Dividend Comparisons
	A's Profitability Ratios	A's Asset Turnover Ratio	A's Dividend Growth
A's Roe	A's Valuation Ratios	A's Financial Strength Ratios	A's Dividend Payout Ratio

Companies with similar Return On Assets at Jul 31 2026, within Healthcare Sector	ROA
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %

Date modified: 2026-09-12T06:19:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.